Cancer Treatment News and Research

RSS

Experts highlight importance of early lung cancer screening

Lung cancer is the second most common cancer in both men and women, and is by far the leading cause of cancer death among both men and women. In 2017, the American Cancer Society estimates more than 200,000 new cases of lung cancer will be diagnosed in the United States, with more than 150,000 deaths.

1 Nov 2017

Breast cancer adjuvant treatment discordance linked to general distrust in healthcare system

Nearly one-third of women with breast cancer went against their doctor's advice and chose not to begin or complete the recommended adjuvant anti-cancer therapy to kill residual tumor cells following surgery, according to a study led by a Johns Hopkins Bloomberg School of Public Health researcher.

1 Nov 2017

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment.

31 Oct 2017

UK charity Macmillan Cancer hires digital nurse to counter medical misinformation

UK charity Macmillan Cancer, in a move to prevent false news and information circulating among patients, has hired a digital nurse.

29 Oct 2017

Timing of DNA damage within checkpoints matters to a cell's fate, study reports

DNA damage occurs routinely within your cells due to sun exposure, smoking and sometimes during the normal process of making new DNA.

26 Oct 2017

Preference for preserving sexual function not strongly reflected in prostate cancer treatment choices

Preserving sexual function was important to many men facing treatment for prostate cancer, according to a recent study by University of North Carolina Lineberger Comprehensive Cancer Center researchers. However, this preference was not strongly reflected in the treatment choices of men with low-risk prostate cancer.

26 Oct 2017

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma.

25 Oct 2017

Proton beam therapy can help improve outcomes in elderly patients with esophageal cancer

A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer.

25 Oct 2017

Stem cell researchers make advance toward long-lasting blood vessel repair

Stem cell researchers at Emory University School of Medicine have made an advance toward having a long-lasting "repair caulk" for blood vessels. The research could form the basis of a treatment for peripheral artery disease, derived from a patient's own cells. Their results were recently published in the journal Circulation.

24 Oct 2017

'Intelligent' nanoparticles could help treat cancer patients

Scientists from the University of Surrey have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells - but which then self-regulate and lose heat before they get hot enough to harm healthy tissue.

24 Oct 2017

Nanodiamonds could prevent infection, improve recovery after root canal treatment

People who undergo root canals may soon have a tiny but powerful ally that could prevent infection after treatment.

24 Oct 2017

So much care it hurts: Unneeded scans, therapy, surgery only add to patients’ ills

When Annie Dennison was diagnosed with breast cancer last year, she readily followed advice from her medical team, agreeing to harsh treatments in the hope of curing her disease.

23 Oct 2017

New CAR-T cell therapy offers effective option for certain blood cancer patients

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers.

19 Oct 2017

Small RNA molecules trigger cancer cells to commit suicide

Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules to trigger a fail-safe mechanism that may protect us from cancer.

19 Oct 2017

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

The Photoelectric Therapy System is a compact and ergonomic superficial X-Ray therapy system operating in the 10 kV to 80 kV range intended for superficial radiotherapy and surface electronic brachytherapy treatment of primary malignant epithelial neoplasms of the skin and keloids.

From Xstrahl 19 Oct 2017

Cascade of costs could push new gene therapy above $1 million per patient

Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country's first gene therapy, Novartis' Kymriah, a leukemia treatment approved in August.

17 Oct 2017

Novel gene expression signature assay could help enhance lymphoma management

Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment of DLBCL may depend on identifying its molecular subtype.

17 Oct 2017

Study helps understand basic mechanisms of mitochondrial DNA maintenance

Researchers at the University of Eastern Finland have discovered a novel mechanism safeguarding mitochondrial DNA. The study, published in PNAS earlier this week, was carried out in close collaboration with research groups from CBMSO in Madrid, Spain, and Umeå University in Sweden.

13 Oct 2017

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up 2 Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer.

12 Oct 2017

Fundamental discovery may open potential for new types of cancer drugs

Many approved cancer therapies target a protein called epidermal growth factor receptor (EGFR) that regulates many crucial cellular processes and can speed the proliferation of tumor cells.

11 Oct 2017

Cancer Treatment News and Research

Experts highlight importance of early lung cancer screening

Breast cancer adjuvant treatment discordance linked to general distrust in healthcare system

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

UK charity Macmillan Cancer hires digital nurse to counter medical misinformation

Timing of DNA damage within checkpoints matters to a cell's fate, study reports

Preference for preserving sexual function not strongly reflected in prostate cancer treatment choices

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Proton beam therapy can help improve outcomes in elderly patients with esophageal cancer

Stem cell researchers make advance toward long-lasting blood vessel repair

'Intelligent' nanoparticles could help treat cancer patients

Nanodiamonds could prevent infection, improve recovery after root canal treatment

So much care it hurts: Unneeded scans, therapy, surgery only add to patients’ ills

New CAR-T cell therapy offers effective option for certain blood cancer patients

Small RNA molecules trigger cancer cells to commit suicide

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

Cascade of costs could push new gene therapy above $1 million per patient

Novel gene expression signature assay could help enhance lymphoma management

Study helps understand basic mechanisms of mitochondrial DNA maintenance

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Fundamental discovery may open potential for new types of cancer drugs

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News